• Je něco špatně v tomto záznamu ?

Characterizing crystal disorder of trospium chloride: a comprehensive,(13) C CP/MAS NMR, DSC, FTIR, and XRPD study

M. Urbanova, A. Sturcova, J. Brus, H. Benes, E. Skorepova, B. Kratochvil, J. Cejka, I. Sedenkova, L. Kobera, O. Policianova, A. Sturc,

. 2013 ; 102 (4) : 1235-48.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031665

Analysis of C cross-polarization magic angle spinning (CP/MAS) nuclear magnetic resonance (NMR), differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), and X-ray powder diffraction data of trospium chloride (TCl) products crystallized from different mixtures of water-ethanol [φ(EtOH) = 0.5-1.0] at various temperatures (0°C, 20°C) and initial concentrations (saturated solution, 30%-50% excess of solvent) revealed extensive structural variability of TCl. Although (13) C CP/MAS NMR spectra indicated broad variety of structural phases arising from molecular disorder, temperature-modulated DSC identified presence of two distinct components in the products. FTIR spectra revealed alterations in the hydrogen bonding network (ionic hydrogen bond formation), whereas the X-ray diffraction reflected unchanged unit cell parameters. These results were explained by a two-component character of TCl products in which a dominant polymorphic form is accompanied by partly separated nanocrystalline domains of a secondary phase that does not provide clear Bragg reflections. These phases slightly differ in the degree of molecular disorder, in the quality of crystal lattice and hydrogen bonding network. It is also demonstrated that, for the quality control of such complex products, (13) C CP/MAS NMR spectroscopy combined with factor analysis (FA) can satisfactorily be used for categorizing the individual samples: FA of (13) C CP/MAS NMR spectra found clear relationships between the extent of molecular disorder and crystallization conditions. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1235-1248, 2013.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031665
003      
CZ-PrNML
005      
20131007125720.0
007      
ta
008      
131002s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jps.23457 $2 doi
035    __
$a (PubMed)23359249
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Urbanova, Martina $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 162 06 Prague 6, Czech Republic.
245    10
$a Characterizing crystal disorder of trospium chloride: a comprehensive,(13) C CP/MAS NMR, DSC, FTIR, and XRPD study / $c M. Urbanova, A. Sturcova, J. Brus, H. Benes, E. Skorepova, B. Kratochvil, J. Cejka, I. Sedenkova, L. Kobera, O. Policianova, A. Sturc,
520    9_
$a Analysis of C cross-polarization magic angle spinning (CP/MAS) nuclear magnetic resonance (NMR), differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), and X-ray powder diffraction data of trospium chloride (TCl) products crystallized from different mixtures of water-ethanol [φ(EtOH) = 0.5-1.0] at various temperatures (0°C, 20°C) and initial concentrations (saturated solution, 30%-50% excess of solvent) revealed extensive structural variability of TCl. Although (13) C CP/MAS NMR spectra indicated broad variety of structural phases arising from molecular disorder, temperature-modulated DSC identified presence of two distinct components in the products. FTIR spectra revealed alterations in the hydrogen bonding network (ionic hydrogen bond formation), whereas the X-ray diffraction reflected unchanged unit cell parameters. These results were explained by a two-component character of TCl products in which a dominant polymorphic form is accompanied by partly separated nanocrystalline domains of a secondary phase that does not provide clear Bragg reflections. These phases slightly differ in the degree of molecular disorder, in the quality of crystal lattice and hydrogen bonding network. It is also demonstrated that, for the quality control of such complex products, (13) C CP/MAS NMR spectroscopy combined with factor analysis (FA) can satisfactorily be used for categorizing the individual samples: FA of (13) C CP/MAS NMR spectra found clear relationships between the extent of molecular disorder and crystallization conditions. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1235-1248, 2013.
650    _2
$a benziláty $x chemie $7 D001561
650    _2
$a diferenciální skenovací kalorimetrie $7 D002152
650    _2
$a krystalizace $7 D003460
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a nortropany $x chemie $7 D009662
650    _2
$a prášková difrakce $7 D033362
650    _2
$a spektroskopie infračervená s Fourierovou transformací $7 D017550
650    _2
$a difrakce rentgenového záření $7 D014961
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sturcova, Adriana $u -
700    1_
$a Brus, Jiri $u -
700    1_
$a Benes, Hynek $u -
700    1_
$a Skorepova, Eliska $u -
700    1_
$a Kratochvil, Bohumil $u -
700    1_
$a Cejka, Jan $u -
700    1_
$a Sedenkova, Ivana $u -
700    1_
$a Kobera, Libor $u -
700    1_
$a Policianova, Olivia $u -
700    1_
$a Sturc, Antonin $u -
773    0_
$w MED00002895 $t Journal of pharmaceutical sciences $x 1520-6017 $g Roč. 102, č. 4 (2013), s. 1235-48
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23359249 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20131007130241 $b ABA008
999    __
$a ok $b bmc $g 995752 $s 830110
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 102 $c 4 $d 1235-48 $i 1520-6017 $m Journal of pharmaceutical sciences $n J Pharm Sci $x MED00002895
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...